Company profile
Aethlon Medical, Inc.
NASDAQ: AEMD · Healthcare · Medical - Devices
#1166 of 1,422 Healthcare companies by revenuebottom-decile growth
EA Score
42DFH 35DQ 66GM 13SS 48
v0.1 · 65/100 weight · provisional
↑ listing tenure, disclosure history · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$7.2M
Employees
9
as of 2026-08-26
Market cap
$1.3M
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02024
Net income-$7.2M-$7.2M2026
Operating income-$7.3M-$7.3M2026
Total assets$6.3M$6.3M2026
Liabilities$1.4M$1.4M2026
Equity$4.9M$4.9M2026
Revenue trend
FY2017 – FY2024 · USD
FY17
FY18
FY20
FY20
FY21
FY22
FY23
FY24
Revenue by segment
Filed disclosures · FY2022
By product
Govt Contract And Grant Revenue100%
By geography
Not disclosed.
The read
What is Aethlon Medical, Inc.’s revenue?
Aethlon Medical, Inc. booked $0 in FY2024 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
City View Green Holdings Inc.——Anything Technologies Media, Inc.32DOncology Pharma Inc.——Burzynski Research Institute, Inc.——The Cannaisseur Group, Inc.8DOdyssey Health, Inc.21DNeighbors
San Diego →Key facts
CEOJames Frakes
SectorHealthcare
IndustryMedical - Devices
HeadquartersSan Diego, CA
ExchangeNASDAQ: AEMD
Employees9
IPO date1999-03-04
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.